Doxycycline+Tylosin Soluble Powder
.png)
.png)
.png)
.png)
Pharmacological chiito
Pharmacodynamics Tylosin imhuka-yakananga macrolide antibiotic ine simba rakasimba pa mycoplasma.Iyo antibacterial spectrum yakafanana neiyo erythromycin, uye hutachiona hweGram-positive bhakitiriya Staphylococcus aureus (inosanganisira penicillin-resistant Staphylococcus aureus), pneumococcus, streptococcus, Bacillus anthracis, Erysipelothrix , Porthusipelothrix rhusiopathianus, Porthusiopathia, Erysipelothrix, Porthusiopathia, Porthusiopathia, Erysipelothrix, Porthusiopathia, Emonococcus, uye Erysipelothrix.Sensitive gram-negative mabhakitiriya anosanganisira Haemophilus, meningococcus uye Pasteurella.Sensitive mabhakitiriya anogona kukura kuramba chigadzirwa ichi, uye Staphylococcus aureus ane chikamu muchinjikwa-kupikisa chigadzirwa ichi uye erythromycin.
Pharmacokinetics
Tylosin inogona kutorwa kubva mudumbu mushure mekutonga kwemuromo, uye huwandu hwepamusoro hunosvika 1 awa mushure mekutonga kwemuromo munguruve, nepo tylosin phosphate isinganyanyi kubatwa.Tylosin inoparadzirwa zvakanyanya mumuviri mushure mekutora, uye nhengo yemuviri mushure mejekiseni ndeye 2 kusvika ku3 nguva yakakwirira kupfuura iyo mushure mekutonga nemuromo, asi hazvisi nyore kupinda mu cerebrospinal fluid.
Kudyidzana kwezvinodhaka
(1) Haifaniri kushandiswa panguva imwe chete nokuti ine chinangwa chakafanana nemamwe macrolides, lincosamines uye amide alcohols.
(2), musanganiswa ne β-lactam wakaratidza kupokana.
Hebei Veyong Pharmaceutical Co., Ltd, yakavambwa muna 2002, iri muShijiazhuang City, Hebei Province, China, padyo neguta guru Beijing.Iye ihombe GMP-yakasimbiswa veterinary drug bhizinesi, ine R&D, kugadzira uye kutengesa kweVeterinary APIs, gadziriro, premixed feed uye feed additives.SeProvincial Technical Center, Veyong yakamisa hurongwa hweR&D hwemishonga mitsva yezvipfuyo, uye ndiyo inozivikanwa pasi rose tekinoroji innovation yakavakirwa bhizinesi rezvipfuyo, kune makumi matanhatu neshanu nyanzvi.Veyong ine mabhesi maviri ekugadzira: Shijiazhuang neOrdos, iyo iyo Shijiazhuang base inovhara nzvimbo ye78,706 m2, ine 13 API zvigadzirwa zvinosanganisira Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, uye 11, gadziriro yekugadzira oral poda, mitsara yekugadzira oral. , premix, bolus, mishonga yezvipembenene nemishonga inouraya utachiona, ects.Veyong inopa APIs, anopfuura zana ega- label gadziriro, uye OEM & ODM sevhisi.
Veyong inokoshesa zvikuru manejimendi eEHS(Environment, Health & Safety) system, uye yakawana ISO14001 uye OHSAS18001 zvitupa.Veyong yakanyorwa mumabhizinesi ari kusimukira maindasitiri muHebei Province uye inogona kuve nechokwadi chekuenderera mberi kwezvigadzirwa.
Veyong yakamisa hurongwa hwekutonga kwemhando yakakwana, yakawana chitupa cheISO9001, chitupa cheChina GMP, chitupa cheAustralia APVMA GMP, chitupa cheEthiopia GMP, chitupa cheIvermectin CEP, uye yakapasa ongororo yeUS FDA.Veyong ine timu yehunyanzvi yekunyoresa, kutengesa uye tekinoroji sevhisi, kambani yedu yakawana kuvimba nerutsigiro kubva kune akawanda vatengi nemhando yepamusoro yechigadzirwa, yepamusoro-yemhando yepamusoro-yekutanga kutengesa uye mushure mekutengesa sevhisi, yakakomba uye yesainzi manejimendi.Veyong yaita kushandira pamwe kwenguva refu nemabhizinesi mazhinji anozivikanwa pasi rose emishonga yemhuka ane zvigadzirwa zvinotengeswa kuEurope, South America, Middle East, Africa, Asia, etc. kupfuura nyika makumi matanhatu nematunhu.
